A media report said that the US Center for Medicare and Medicaid released a preliminary list of 101 generic drugs.

The Nifty Pharma index has so far this year gained 54.42 percent while the benchmark Nifty advanced 26.94 percent in the same ...

Stay up-to-date with the Cipla Stock Liveblog, your trusted source for real-time updates and thorough analysis of a prominent ...

The Indian market is expected to consolidate on Thursday, influenced by mixed global cues. The Nifty futures experienced a ...

Volatility is expected to continue in the market, with support at the current week's low. Below are some trading ideas for ...

Discover the Cipla Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a ...

Cipla (EU) Ltd. will acquire the entire 6.9% equity interest of Jiangsu Xidi Pharmaceuticals Co. in the subsidiary for 35 ...

Indian pharma company Cipla has made another play in the digital medicine category by taking a near-12% stake in start-up Wellthy Therapeutics. Under the terms of their agreement Wellthy and Cipla ...

UBS highlights growth opportunities for Sun Pharma and Cipla while raising alarms about profitability pressures in the Indian ...

The Sensex gained 144.31 points, or 0.18, to settle at 81467.1, while the Nifty gained 16.5 points, or 0.07, to close at ...

CIPLA daily chart is indicating a continued push higher through 1758-60 zone going forward. This would terminate Minor Wave 5 Grey of Intermediate Wave (5) Orange and complete the uptrend at larger ...

The pharmaceutical industry is poised for an 8.5% revenue growth, spurred by domestic formulations and niche US market ...